NEW YORK (GenomeWeb News) – Cancer diagnostics company Genetix Group has won a contract from the National Health Service of Scotland to develop and build a national network of automated cytogenetic analysis systems, the UK-based company said today.
The network will connect NHS Scotland’s five cytogenetic labs in Aberdeen, Dundee, Edinburgh, Glasgow, and Inverness, by connecting over 70 of the company’s CytoVision workstations. The company said that it offers an integrated, standardized, and automated cytogenetic analysis solution.
The network will replace microscope-based chromosome analysis methods, and it will allow the labs to share digital images using the CytoVision’s web service and the NHS Scotland wide area network.
"The CytoVision network enables us to implement a number of significant improvements which the NHS has targeted as priorities — with the primary goal to provide a uniformly high level of service to every patient in Scotland,” NHS Director of Cytogenetic Services Eddy Maher said in a statement.
Financial terms of the agreement were not released.